Project Grant R01EY036697

Award Date 7/1/25
Completion Date 4/30/29
Dollars Obligated $586K
Federal Grant Program
93.867
Assistance Type
Project Grant
Place of Performance
Detroit, MI 48201, USA
Similar Awards
The National Eye Institute (NEI) awarded a $1,083,078 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of California, Irvine (UCI) to conduct research on the role of monocytes and neutrophils in fungal keratitis. The project aims to examine neutrophil activation and the effect of monocyte depletion on neutrophil function in infected corneas, investigate the role of ICAM-1+ neutrophils and the HV1 proton channel in fungal keratitis, and explore the...
The National Eye Institute (NEI) awarded a $488,639 Project Grant under the Vision Research federal grant program (CFDA 93.867) to the University of Pittsburgh to identify the mechanisms underlying the enhanced virulence of an extensively drug-resistant (XDR) strain of Pseudomonas aeruginosa that has caused a concerning outbreak of keratitis infections. The funding will support research to systematically test the unique virulence factors of this outbreak strain and develop more effective...
The National Eye Institute (NEI) awarded a Project Grant (CFDA 93.867 - Vision Research) in the amount of $753,189 to Trustees of Boston University, doing business as Boston University Medical Campus, with a period of performance from August 1, 2024 to May 31, 2029. The grant will support research to identify novel therapeutic targets for corneal epithelial defects by revealing the differential roles of basal epithelial cells in the central cornea, limbus, and conjunctiva in corneal health and...
This $201,825 Project Grant award from the National Eye Institute (NEI) Vision Research program (CFDA 93.867) supports research to evaluate the use of condensin inhibitors as a potential topical treatment for Pseudomonas aeruginosa bacterial eye infections. The lead investigator, Dr. Valentin Rybenkov at the University of Oklahoma, will collaborate with Dr. Michelle Callegan at the University of Oklahoma Health Sciences Center to conduct in vivo studies examining the toxicity, corneal...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research federal grant program (CFDA 93.867), supports research to understand the development and function of corneal lens-secreting cells in the human eye. The $543,037 award, effective September 1, 2024 through May 31, 2028, will fund investigations into the genetic and molecular mechanisms underlying corneal development and function. Key research objectives include identifying transcription factors and...
This federal Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $428,152 to Wayne State University to support research on the role of the protease matriptase in maintaining corneal epithelial barrier function and promoting corneal tissue repair. The award will fund a 5-year project to utilize mouse models and 3D cellular models of the human cornea to characterize matriptase's function in corneal homeostasis and identify its substrates and signaling...
The National Eye Institute (NEI) awarded a $882,500 Project Grant under the Vision Research program (CFDA 93.867) to the University of Washington (UW) to conduct research on photoreceptor induction in wounded corneas. The project aims to investigate how light modulates corneal wound healing through an opsin-dependent mechanism, including testing light regimens, characterizing signal transduction in opsin-expressing cells, and examining diffusible factors involved in opsin induction and corneal...
This Project Grant award from the National Eye Institute (NEI), under the Vision Research program (CFDA 93.867), aims to develop a rapid, culture-independent diagnostic approach for detecting pathogens and antimicrobial resistance in sight-threatening ocular infections. The $425,000 award, effective August 1, 2024 through July 31, 2029, will support the Massachusetts Eye and Ear Infirmary in creating a metagenomic sequencing-based platform that uses portable nanopore sequencers to provide...
This Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) provides $615,979 to Wayne State University to investigate a promising peptide-based combination therapy that targets hyperglycemia-responsive circuits in the cornea to prevent high glucose-induced damage and restore structure and function in the diabetic cornea. The award supports in vitro and in vivo assessments to establish the therapeutic role of the TB4 and VIP combination treatment and elucidate the...
The National Eye Institute (NEI) awarded a $974,348 Project Grant under the Vision Research program (CFDA 93.867) to Wayne State University to conduct research on metabolic signatures in the vitreous of patients with bacterial and fungal endophthalmitis. The research aims to identify potential biomarkers for diagnosing endophthalmitis and guiding appropriate antimicrobial therapy. Specifically, the project will perform untargeted metabolomics analysis on vitreous samples from culture-positive...

The National Eye Institute (NEI) awarded a $586,258 Project Grant under the Vision Research program (CFDA 93.867) to Wayne State University to conduct research on the role of eosinophils in modulating the corneal response to Pseudomonas aeruginosa infection. The research, spanning from Jul 1, 2025 to Apr 30, 2029, aims to characterize the spatiotemporal distribution, phenotypic profiles, and proteomic changes of eosinophils during corneal inflammation and infection using mouse models. The findings are expected to elucidate the currently undefined role of eosinophils in the corneal microenvironment and explore their potential as a therapeutic target to improve outcomes for microbial keratitis, a leading cause of blindness.

Generated 8/5/25, 3:12 AM